Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Generian Pharmaceuticals
AddedFeb 15, 2024
UpdatedJun 18, 2026
Generian Pharmaceuticals

Generian Pharmaceuticals

Series B

Generian, a drug discovery startup, pioneers innovative treatments for chronic diseases using small molecules to restore cellular balance.

HQ
Pittsburgh, PA, US
Founded
2019
Overview
Compare
Fundraising
Employees
Website

Generian Pharmaceuticals, founded by leading researchers in aging, small molecule drug development, and E3 ubiquitin ligase biology, focuses on discovering first-in-class, gain-of-function drugs. Their core mission is to activate key cellular networks linked to quality control and metabolism, offering a novel approach to treating a broad range of chronic diseases. Generian aims to address the limitations of biologics by developing small molecule therapeutics that are more convenient, accessible, and economically sustainable for patients.

Notable figures affiliated with Generian include top scientists in their respective fields, contributing to the company's innovative edge. The startup has made significant strides in creating a robust drug discovery pipeline, targeting diseases with high unmet needs. By focusing on oral small molecule therapeutics, Generian is poised to transform treatment paradigms and improve patient outcomes across various chronic conditions.

Generian Pharmaceuticals - Similar Companies

BridGene Biosciences logo

BridGene Biosciences

Genteric logo

Genteric

Deep Apple Therapeutics logo

Deep Apple Therapeutics

deepappletx.com

Cambrian BioPharma logo

Cambrian BioPharma

cambrianbio.com

Septerna logo

Septerna

septerna.com

Elgia Therapeutics logo

Elgia Therapeutics

Generate Biomedicines logo

Generate Biomedicines

EIR Pharmaceuticals logo

EIR Pharmaceuticals

Aria Pharmaceuticals logo

Aria Pharmaceuticals

Geneicd logo

Geneicd

Terns Pharmaceuticals logo

Terns Pharmaceuticals

ternspharma.com

Geneticure logo

Geneticure

geneticure.com

GentiBio logo

GentiBio

gentibio.com

Design Pharmaceuticals logo

Design Pharmaceuticals

Epiodyne logo

Epiodyne

Generian Pharmaceuticals - Quick Facts

Who are Generian Pharmaceuticals' competitors?

Companies similar to Generian Pharmaceuticals include BridGene Biosciences, Genteric, Deep Apple Therapeutics and Cambrian BioPharma.

When was Generian Pharmaceuticals founded?

Generian Pharmaceuticals was founded in 2019.

Where is Generian Pharmaceuticals' headquarters located?

Generian Pharmaceuticals' headquarters is located in Pittsburgh, PA, US.

When was Generian Pharmaceuticals' last funding round?

Generian Pharmaceuticals' most recent funding round was for $13M (USD) in October 2019.

How much has Generian Pharmaceuticals raised to-date?

As of Oct 1, 2019, Generian Pharmaceuticals has raised a total of $13M (USD).

How many employees does Generian Pharmaceuticals have?

Generian Pharmaceuticals has 6 employees as of Feb 5, 2024.

Generian Pharmaceuticals - Classification

Ownership
  • Private
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • Global
Model
  • Platform
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Drug Discovery
Tags
  • Biotech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 13 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified